Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment

Daisuke Kadowaki, Shoichi Sakaguchi, Yohei Miyamoto, Kazuaki Taguchi, Nanako Muraya, Yuki Narita, Keizo Sato, Victor Tuan Giam Chuang, Toru Maruyama, Masaki Otagiri, Sumio Hirata

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Uric acid exerts an important antioxidant effect against external oxidative stress under physiological conditions. However, uric acid itself can increase oxidative stress via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in adipocytes and vascular cells. Uric acid transporter 1 is involved in the generation of this oxidative stress. Furthermore, uric acid locally activates the renin-angiotensin system, thus producing angiotensin II and subsequently increasing intracellular oxidative stress. Ben-zbromarone has been reported to suppress uric acid reabsorption via uric acid transporter 1 inhibition in renal tubular cells. In this study we evaluated the in vitro antioxidant effect of benzbromarone from several perspectives. First, the direct radical-trapping capacity of benzbromarone was measured by chemilumines-cence assay and electron paramagnetic resonance spectroscopy. Second, the intracellular antioxidant activity of benzbromarone in hyperuricemia was evaluated using endothelial cells. In light of these results, benz-bromarone is hypothesized directly to scavenge the superoxide anion radical. In addition, benzbromarone inhibited reactive oxygen species production that was induced by angiotensin II or uric acid in endothelial cells. These findings suggest that benzbromarone possesses the ability directly to scavenge radicals and may act as an antioxidant against uric acid and angiotensin II-induced oxidative stresses in endothelial cells at therapeutically achievable levels in blood.

Original languageEnglish
Pages (from-to)487-492
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume38
Issue number3
DOIs
Publication statusPublished - 2015 Mar 1
Externally publishedYes

Fingerprint

Benzbromarone
Hyperuricemia
Uric Acid
Antioxidants
Oxidative Stress
Angiotensin II
Endothelial Cells
Superoxides
Electron Spin Resonance Spectroscopy
Renin-Angiotensin System
NADP
Adipocytes
Blood Vessels
Reactive Oxygen Species
Spectrum Analysis
Oxidoreductases
Kidney

Keywords

  • Benzbromarone
  • Endothelial dysfunction
  • Reactive oxygen species
  • Uric acid

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment. / Kadowaki, Daisuke; Sakaguchi, Shoichi; Miyamoto, Yohei; Taguchi, Kazuaki; Muraya, Nanako; Narita, Yuki; Sato, Keizo; Chuang, Victor Tuan Giam; Maruyama, Toru; Otagiri, Masaki; Hirata, Sumio.

In: Biological and Pharmaceutical Bulletin, Vol. 38, No. 3, 01.03.2015, p. 487-492.

Research output: Contribution to journalArticle

Kadowaki, D, Sakaguchi, S, Miyamoto, Y, Taguchi, K, Muraya, N, Narita, Y, Sato, K, Chuang, VTG, Maruyama, T, Otagiri, M & Hirata, S 2015, 'Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment', Biological and Pharmaceutical Bulletin, vol. 38, no. 3, pp. 487-492. https://doi.org/10.1248/bpb.b14-00514
Kadowaki, Daisuke ; Sakaguchi, Shoichi ; Miyamoto, Yohei ; Taguchi, Kazuaki ; Muraya, Nanako ; Narita, Yuki ; Sato, Keizo ; Chuang, Victor Tuan Giam ; Maruyama, Toru ; Otagiri, Masaki ; Hirata, Sumio. / Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment. In: Biological and Pharmaceutical Bulletin. 2015 ; Vol. 38, No. 3. pp. 487-492.
@article{c031354c46c640ca8f65909a2b057730,
title = "Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment",
abstract = "Uric acid exerts an important antioxidant effect against external oxidative stress under physiological conditions. However, uric acid itself can increase oxidative stress via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in adipocytes and vascular cells. Uric acid transporter 1 is involved in the generation of this oxidative stress. Furthermore, uric acid locally activates the renin-angiotensin system, thus producing angiotensin II and subsequently increasing intracellular oxidative stress. Ben-zbromarone has been reported to suppress uric acid reabsorption via uric acid transporter 1 inhibition in renal tubular cells. In this study we evaluated the in vitro antioxidant effect of benzbromarone from several perspectives. First, the direct radical-trapping capacity of benzbromarone was measured by chemilumines-cence assay and electron paramagnetic resonance spectroscopy. Second, the intracellular antioxidant activity of benzbromarone in hyperuricemia was evaluated using endothelial cells. In light of these results, benz-bromarone is hypothesized directly to scavenge the superoxide anion radical. In addition, benzbromarone inhibited reactive oxygen species production that was induced by angiotensin II or uric acid in endothelial cells. These findings suggest that benzbromarone possesses the ability directly to scavenge radicals and may act as an antioxidant against uric acid and angiotensin II-induced oxidative stresses in endothelial cells at therapeutically achievable levels in blood.",
keywords = "Benzbromarone, Endothelial dysfunction, Reactive oxygen species, Uric acid",
author = "Daisuke Kadowaki and Shoichi Sakaguchi and Yohei Miyamoto and Kazuaki Taguchi and Nanako Muraya and Yuki Narita and Keizo Sato and Chuang, {Victor Tuan Giam} and Toru Maruyama and Masaki Otagiri and Sumio Hirata",
year = "2015",
month = "3",
day = "1",
doi = "10.1248/bpb.b14-00514",
language = "English",
volume = "38",
pages = "487--492",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment

AU - Kadowaki, Daisuke

AU - Sakaguchi, Shoichi

AU - Miyamoto, Yohei

AU - Taguchi, Kazuaki

AU - Muraya, Nanako

AU - Narita, Yuki

AU - Sato, Keizo

AU - Chuang, Victor Tuan Giam

AU - Maruyama, Toru

AU - Otagiri, Masaki

AU - Hirata, Sumio

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Uric acid exerts an important antioxidant effect against external oxidative stress under physiological conditions. However, uric acid itself can increase oxidative stress via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in adipocytes and vascular cells. Uric acid transporter 1 is involved in the generation of this oxidative stress. Furthermore, uric acid locally activates the renin-angiotensin system, thus producing angiotensin II and subsequently increasing intracellular oxidative stress. Ben-zbromarone has been reported to suppress uric acid reabsorption via uric acid transporter 1 inhibition in renal tubular cells. In this study we evaluated the in vitro antioxidant effect of benzbromarone from several perspectives. First, the direct radical-trapping capacity of benzbromarone was measured by chemilumines-cence assay and electron paramagnetic resonance spectroscopy. Second, the intracellular antioxidant activity of benzbromarone in hyperuricemia was evaluated using endothelial cells. In light of these results, benz-bromarone is hypothesized directly to scavenge the superoxide anion radical. In addition, benzbromarone inhibited reactive oxygen species production that was induced by angiotensin II or uric acid in endothelial cells. These findings suggest that benzbromarone possesses the ability directly to scavenge radicals and may act as an antioxidant against uric acid and angiotensin II-induced oxidative stresses in endothelial cells at therapeutically achievable levels in blood.

AB - Uric acid exerts an important antioxidant effect against external oxidative stress under physiological conditions. However, uric acid itself can increase oxidative stress via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in adipocytes and vascular cells. Uric acid transporter 1 is involved in the generation of this oxidative stress. Furthermore, uric acid locally activates the renin-angiotensin system, thus producing angiotensin II and subsequently increasing intracellular oxidative stress. Ben-zbromarone has been reported to suppress uric acid reabsorption via uric acid transporter 1 inhibition in renal tubular cells. In this study we evaluated the in vitro antioxidant effect of benzbromarone from several perspectives. First, the direct radical-trapping capacity of benzbromarone was measured by chemilumines-cence assay and electron paramagnetic resonance spectroscopy. Second, the intracellular antioxidant activity of benzbromarone in hyperuricemia was evaluated using endothelial cells. In light of these results, benz-bromarone is hypothesized directly to scavenge the superoxide anion radical. In addition, benzbromarone inhibited reactive oxygen species production that was induced by angiotensin II or uric acid in endothelial cells. These findings suggest that benzbromarone possesses the ability directly to scavenge radicals and may act as an antioxidant against uric acid and angiotensin II-induced oxidative stresses in endothelial cells at therapeutically achievable levels in blood.

KW - Benzbromarone

KW - Endothelial dysfunction

KW - Reactive oxygen species

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=84937198408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937198408&partnerID=8YFLogxK

U2 - 10.1248/bpb.b14-00514

DO - 10.1248/bpb.b14-00514

M3 - Article

VL - 38

SP - 487

EP - 492

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 3

ER -